PHARMACEUTICAL COMPOSITION CONTAINING GEFITINIB, ADMINISTRABLE TO PATIENTS WITH LACTOSE INTOLERANCE AND HAVING IMPROVED DOSING CONVENIENCE

The present invention relates to a pharmaceutical composition containing gefitinib as a pharmaceutically active ingredient. When the present invention is prepared, the weight and the volume of the final formulation can be optimized in terms of dosing convenience for patients and can be administered...

Full description

Saved in:
Bibliographic Details
Main Authors JEONG, Hyun Jun, MIN, Mi Hong, AHN, Byung-Nak
Format Patent
LanguageEnglish
French
Korean
Published 06.07.2017
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a pharmaceutical composition containing gefitinib as a pharmaceutically active ingredient. When the present invention is prepared, the weight and the volume of the final formulation can be optimized in terms of dosing convenience for patients and can be administered to patients with lactose intolerance. La présente invention concerne une composition pharmaceutique contenant du géfitinib utilisé comme principe pharmaceutiquement actif. Lorsque la présente invention est préparée, le poids et le volume de la formulation finale peuvent être optimisés en termes de commodité de dosage pour les patients et ladite formulation finale peut être administré à des patients présentant une intolérance au lactose. 본 발명은 게피티니브를 약리학적 활성성분으로 하는 약제학적 조성물에 관한 것이다. 본 발명은 제제화했을 때의 최종 제형의 중량 및 부피가 환자의 복용편의성의 측면에서 최적화될 수 있고 유당불내성 환자에게 투여가 가능하다.
Bibliography:Application Number: WO2016KR14300